Chronic Traumatic Encephalopathy: A Brief Overview.

Area of Science:

• Neurology
• Neuroscience
• Sports Medicine

Background:

• Chronic Traumatic Encephalopathy (CTE) is a progressive neurodegenerative disease associated with repetitive mild traumatic brain injuries (TBIs).
• It is increasingly diagnosed in athletes, particularly American football players, and military veterans.
• CTE is characterized by the accumulation of phosphorylated tau (p-tau) protein, neuroinflammation, and distinct clinical presentations.

Purpose of the Study:

• To review the current understanding of CTE's neuropathology, clinical manifestations, and potential risk factors.
• To discuss the lack of disease-modifying treatments and explore emerging therapeutic and preventive strategies.
• To highlight the importance of advanced research techniques and public awareness in advancing CTE understanding.

Main Methods:

• Review of existing literature on CTE.
• Analysis of neuropathological findings, including tauopathy and neuroinflammation.
• Examination of clinical phenotypes, genetic associations, and TBI treatment implications.

Main Results:

• CTE presents with a unique neuropathological signature of p-tau accumulation, microgliosis, and astrocytosis.
• Clinical symptoms manifest in two subtypes: affective changes or cognitive impairment.
• No definitive genetic risk factors are identified, though ApoE4 carriers may experience worse outcomes post-TBI.

Conclusions:

• Currently, no disease-modifying treatments exist for CTE.
• Time-sensitive TBI treatments may offer a potential therapeutic option.
• Prevention through education on safe techniques and accessible neuropsychiatric assessments is vital for mitigating CTE risks.